Journal of Affective Disorders
Volume 83, Issue 1 , Pages 83-87 , 15 November 2004

Prevalence of social phobia in a clinical sample of drug dependent patients

  • Grégoire Zimmermann

      Affiliations

    • Substance Abuse Division, University Department of Adult Psychiatry, CH-1008 Prilly-Lausanne, Switzerland
    • Department of Psychology, University of Lausanne, Switzerland
    • ,
  • Marie A. Pin

      Affiliations

    • Substance Abuse Division, University Department of Adult Psychiatry, CH-1008 Prilly-Lausanne, Switzerland
    • ,
  • Sonia Krenz

      Affiliations

    • Substance Abuse Division, University Department of Adult Psychiatry, CH-1008 Prilly-Lausanne, Switzerland
    • ,
  • Adriana Bouchat

      Affiliations

    • Substance Abuse Division, University Department of Adult Psychiatry, CH-1008 Prilly-Lausanne, Switzerland
    • ,
  • Bernard Favrat

      Affiliations

    • Substance Abuse Division, University Department of Adult Psychiatry, CH-1008 Prilly-Lausanne, Switzerland
    • ,
  • Jacques Besson

      Affiliations

    • Substance Abuse Division, University Department of Adult Psychiatry, CH-1008 Prilly-Lausanne, Switzerland
    • ,
  • Daniele F. Zullino

      Affiliations

    • Substance Abuse Division, University Department of Adult Psychiatry, CH-1008 Prilly-Lausanne, Switzerland
    • Corresponding Author InformationCorresponding author. Tel.: +41 21 316 16 16; fax: +41 21 316 16 26.

Received 9 February 2004 ,Revised 10 May 2004 ,Accepted 10 May 2004.

References 

  1. American Psychiatric Association. Diagnostic Criteria from DSM-IV. Washington, DC: American Psychiatric Association; 1994;
  2. Angst J, Dobler-Mikola A. The Zurich Study: V. Anxiety and phobia in young adults. Eur. Arch. Psychiatr. Neurol. Sci. 1985;235(3):171–178
  3. Bisserbe JC, Weiller E, Boyer P, Lepine JP, Lecrubier Y. Social phobia in primary care: level of recognition and drug use. Int. Clin. Psychopharmacol. 1996;11(Suppl. 3):25–28
  4. Blanco C, Antia SX, Liebowitz MR. Pharmacotherapy of social anxiety disorder. Biol. Psychiatry. 2002;51(1):109–120
  5. Brunello N, den Boer JA, Judd LL, Kasper S, Kelsey JE, Lader M, et al. Social phobia: diagnosis and epidemiology, neurobiology and pharmacology, comorbidity and treatment. J. Affect. Disord. 2000;60(1):61–74
  6. Furmark T, Tillfors M, Everz P, Marteinsdottir I, Gefvert O, Fredrikson M. Social phobia in the general population: prevalence and sociodemographic profile. Soc. Psychiatry Psychiatr. Epidemiol. 1999;34(8):416–424
  7. Heimberg RG, Horner KJ, Juster HR, Safren SA, Brown EJ, Schneier FR, et al. Psychometric properties of the Liebowitz social anxiety scale. Psychol. Med. 1999;29(1):199–212
  8. Heimberg RG, Stein MB, Hiripi E, Kessler RC. Trends in the prevalence of social phobia in the United States: a synthetic cohort analysis of changes over four decades. Eur. Psychiatr. 2000;15(1):29–37
  9. Judd LL. Social phobia: a clinical overview. J. Clin. Psychiatry. 1994;55:5–9(Suppl.)
  10. Katzelnick DJ, Greist JH. Social anxiety disorder: an unrecognized problem in primary care. J. Clin. Psychiatry. 2001;62(Suppl. 1):11–15
  11. Kessler RC, McGonagle KA, Zhao S, Nelson CB, Hughes M, Eshleman S, et al. Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey. Arch. Gen. Psychiatry. 1994;51(1):8–19
  12. Kessler RC, Stein MB, Berglund P. Social phobia subtypes in the National Comorbidity Survey. Am. J. Psychiatry. 1998;155(5):613–619
  13. Kessler RC, Stang P, Wittchen HU, Stein M, Walters EE. Lifetime co-morbidities between social phobia and mood disorders in the US National Comorbidity Survey. Psychol. Med. 1999;29(3):555–567
  14. Krenz, S., Dieckmann, S., Faurat, B., Spagnoli, J., Leutwyler, J., Schnyder, C., Daeppen, J.B., Besson, J. French version of the addiction severity index. (5th edition): validity and reliabilty among Swiss opiate-dependent patients. Eur. Addict. Res. (in press).
  15. Liebowitz MR. Delineating social phobia. Br. J. Psychiatry. 1987;150:718–719
  16. Liebowitz MR. Update on the diagnosis and treatment of social anxiety disorder. J. Clin. Psychiatry. 1999;60(Suppl. 18):22–26
  17. Lipsitz JD, Schneier FR. Social phobia. Epidemiology and cost of illness. PharmacoEconomics. 2000;18(1):23–32
  18. Magee WJ, Eaton WW, Wittchen HU, McGonagle KA, Kessler RC. Agoraphobia, simple phobia, and social phobia in the National Comorbidity Survey. Arch. Gen. Psychiatry. 1996;53(2):159–168
  19. McLellan AT, Luborsky L, Cacciola J, Griffith J, Evans F, Barr HL, et al. New data from the Addiction Severity Index. Reliability and validity in three centers. J. of Nerv. Ment. Dis. 1985;173(7):412–423
  20. Mennin DS, Fresco DM, Heimberg RG, Schneier FR, Davies SO, Liebowitz MR. Screening for social anxiety disorder in the clinical setting: using the Liebowitz Social Anxiety Scale. J. Anxiety Disord. 2002;16(6):661–673
  21. Mennin DS, Fresco DM, Heimberg RG, Schneier FR, Davies SO, Liebowitz MR. Screening for social anxiety disorder in the clinical setting: using the Liebowitz Social Anxiety Scale. J. Anxiety Disord. 2002;16(6):661–673
  22. Myrick H, Brady KT. Social phobia in cocaine-dependent individuals. Am. J. Addict. 1997;6(2):99–104
  23. Rapaport MH, Paniccia G, Judd LL. A review of social phobia. Psychopharmacol. Bull. 1995;31(1):125–129
  24. Sareen L, Stein M. A review of the epidemiology and approaches to the treatment of social anxiety disorder. Drugs. 2000;59(3):497–509
  25. Stein MB. Phenomenology and epidemiology of social phobia. Int. Clin. Psychopharmacol. 1997;12(Suppl. 6):S23–S26
  26. Stein MB, Chavira DA. Subtypes of social phobia and comorbidity with depression and other anxiety disorders. J. Affect. Disord. 1998;50(1):S11–S16
  27. Thomas SE, Thevos AK, Randall CL. Alcoholics with and without social phobia: a comparison of substance use and psychiatric variables. J. Stud. Alcohol. 1999;60(4):472–479
  28. Wacker HR. Diagnosis, epidemiology and comorbidity of anxiety disorders. Ther. Umsch. 1997;54(10):559–563
  29. Wacker HR, Müllejans R, Klein KH, Battegay R. Identification of cases of anxiety disorders and affective disorders in the community according to ICD-10 and DSM-III-R using the composite international diagnostic interview (CIDI). Int. J. Methods Psychiatr. Res. 1992;2:91–100
  30. Weiller E, Bisserbe JC, Boyer P, Lepine JP, Lecrubier Y. Social phobia in general health care: an unrecognised undertreated disabling disorder. Br. J. Psychiatry. 1996;168(2):169–174
  31. Wittchen HU. The many faces of social anxiety disorder. Int. Clin. Psychopharmacol. 2000;15(Suppl. 1):S7–S12
  32. Yao SN, Note I, Fanget F, Albuisson E, Bouvard M, Jalenques I, et al. Social anxiety in patients with social phobia: validation of the Liebowitz social anxiety scale: the French version. Encephale. 1999;25(5):429–435
  33. Zamorski MA, Ward RK. Social anxiety disorder: common, disabling, and treatable. J. Am. Board Fam. Pract. 2000;13(4):251–260

PII: S0165-0327(04)00178-8

doi: 10.1016/j.jad.2004.05.003

Journal of Affective Disorders
Volume 83, Issue 1 , Pages 83-87 , 15 November 2004

Article Tools